One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation

Tanaka Tomohiro; Renner Eberhard L.; Selzner Nazia; Therapondos George; Lilly Leslie B.

首页> 外文期刊>Canadian journal of gastroenterology & hepatology. >One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation

【24h】

One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation

机译：一年的乙肝免疫球蛋白加替诺福韦疗法可安全有效地预防肝移植术后复发性乙肝感染

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND: Hepatitis B immunoglobulin (HBIG) given in combination with a nucleos(t)ide analogue has reduced the rate of recurrent hepatitis B virus (HBV) infection following liver transplantation (LT); however, the most effective protocol remains unclear.

机译：背景：乙型肝炎免疫球蛋白（HBIG）与核苷酸（t）ide类似物联合使用可降低肝移植（LT）后复发性乙型肝炎病毒（HBV）感染率;但是，最有效的协议仍不清楚。

著录项

来源
《Canadian journal of gastroenterology & hepatology.》 |2014年第1期|共4页
作者
Tanaka Tomohiro; Renner Eberhard L.; Selzner Nazia; Therapondos George; Lilly Leslie B.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
HBIG; Hepatitis B; Liver transplantation; Tenofovir;

机译：HBIG;乙型肝炎;肝移植;替诺福韦;

相似文献

外文文献
中文文献
专利

1. One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation [J] . Tanaka Tomohiro, Renner Eberhard L., Selzner Nazia, Canadian journal of gastroenterology & hepatology. . 2014,第1期

机译：一年的乙肝免疫球蛋白加替诺福韦疗法可安全有效地预防肝移植术后复发性乙肝感染
2. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients [J] . Fernandez I., Loinaz C., Hernandez O., Transplant infectious disease: an official journal of the Transplantation Society . 2015,第5期

机译：乙肝免疫球蛋白停药后使用替诺福韦/恩替卡韦单药可安全有效地预防肝移植受者乙肝
3. Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. [J] . Di Paolo D, Tisone G, Piccolo P, Transplantation: Official Journal of the Transplantation Society . 2004,第8期

机译：低剂量的乙肝免疫球蛋白与拉米夫定一起“按需”给药：在肝移植后的长期随访中，预防乙肝病毒复发的高成本效益方法。
4. Genetics in viral hepatitis: role of HLA class I and II alleles in hepatitis C virus infection [C] . R.THIMME, C. NEUMANN-HAEFELI Falk Symposium . 2007

机译：病毒性肝炎的遗传学：HLA I类和II等位基因在丙型肝炎病毒感染中的作用
5. The efficacy of a triple medication therapy to prevent recurrent Hepatitis C post liver transplantation: A pilot study. [D] . Strutynski, Katherine M. 2011

机译：一项三联药物治疗预防肝移植后复发丙型肝炎的功效。
6. One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation [O] . Tomohiro Tanaka, Eberhard L Renner, Nazia Selzner, 2014

机译：一年的乙肝免疫球蛋白加替诺福韦疗法可安全有效地预防肝移植术后复发性乙肝感染
7. One Year of Hepatitis B Immunoglobulin Plus Tenofovir Therapy is Safe and Effective in Preventing Recurrent Hepatitis B Infection Post-Liver Transplantation [O] . Tomohiro Tanaka, Eberhard L Renner, Nazia Selzner, 2014

机译：一年的乙型肝炎免疫球蛋白加上替诺福韦治疗安全有效地预防肝脏移植后复发性乙型肝炎感染
8. Clinical Significance of Low Molecular Weight (7-8s) Immunoglobulin M Antibody to Hepatitis B Core Antigen in Chronic Hepatitis B Virus Infections [R] . Sjogern, M. H., Bancroft, W. H., Hoofnagle, J. H., 1986

机译：低分子量（7-8s）免疫球蛋白m抗体对乙型肝炎核心抗原在慢性乙型肝炎病毒感染中的临床意义

One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation

摘要

著录项

相似文献

相关主题

期刊订阅